{"nct_id":"NCT05226598","title":"Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2022-03-24","start_date_type":"ACTUAL","primary_completion_date":"2024-09-24","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-09","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}